Issue 1/2026

Stem cells-derived suicide gene exosomes: a promising platform for innovative cancer therapy (1 — 9)

Dajana Vanova, Michal Andrezal, Ursula Altanerova, Miroslava Matuskova,  Cestmir Altaner

DOI: doi:10.4149/neo_2025_251119N487

Immune checkpoint remodeling across disease progression in multiple myeloma (10 — 25)

Zuzana Valuskova, Dana Cholujova, Gabor Beke, Milan Hucko, Lubos Klucar, Gabriela Grofova, Lubos Drgona,  Jana Jakubíková

DOI: doi:10.4149/neo_2025_251026N448

SLC44A1 promotes AML progression and chemoresistance by regulating the Notch signaling pathway (26 — 36)

Shuyun Cao, Chengyun Pan, Xiuying Hu, Tianzhen Hu, Yanju Li, Qin Fang,  Jishi Wang

DOI: doi:10.4149/neo_2025_250518N209

Bystin-like protein forms a functional complex with DDX49 to enhance thyroid cancer progression (37 — 51)

Yue Wang, Xiaoxiao Xing, Dongpo Zhang, Tao Sun, Yuren Zhang, Jun Li,  Daixiang Liao,  Junyi Li

DOI: doi:10.4149/neo_2025_250729N326

Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort study (52 — 58)

Chen Li, Letao Lin, Shuanggang Chen, Gulijiayina Nuerhashi, Hongtong Tan, Chunyong Wen, Yujia Wang, Guanglei Zheng, Ruizhi Tang, Jiayu Pan,  Lujun Shen,  Weijun Fan

DOI: doi:10.4149/neo_2025_200508N198

DNA methylation-predicted GDF-15 and mortality in cancer survivors: a cohort study (59 — 67)

 Jingying Nong,  Kejian Shi, Yi Zhang

DOI: doi:10.4149/neo_2025_250629N284

Prognostic value and clinical significance of tumoral PD-L1 and stromal α-SMA expression in diffuse pleural mesothelioma (68 — 73)

Yeqi Sun, Lan Li, Lei Cai, Jihua Yang, Jun Qian,  Fajiu Wang,  Lifeng Wang

DOI: doi:10.4149/neo_2026_251018N437